Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

News

Should the U.S. consider marijuana a lower-risk drug?

Published

on

The U.S. Department of Health and Human Services (HHS) has proposed a relaxation of restrictions on marijuana, marking a significant step following a review request from the Biden Administration last year.

As the trend toward legalisation gains momentum across nearly 40 U.S. states, the move could signal a pivotal shift in marijuana’s legal status both at state and federal levels.

While marijuana has been legalised for various forms of use in almost 40 U.S. states, it remains prohibited in certain states and under federal law.

The HHS’s recommendation to reclassify marijuana reflects a push to acknowledge its potential benefits while demoting its perceived risks, in alignment with a growing majority of Americans who support broader legalisation.

The HHS conveyed its scheduling recommendation to the Drug Enforcement Agency (DEA) on Tuesday, as per President Biden’s directive.

The DEA, tasked with enforcing drug-related laws, possesses the authority to schedule or reschedule drugs under the Controlled Substances Act.

Presently designated as a schedule I drug, on par with heroin and LSD, marijuana’s classification implies high potential for abuse and lacks accepted medical applications.

The HHS’s proposal, in contrast, suggests a reclassification of marijuana to acknowledge its moderate to low potential for dependence and reduced abuse likelihood, likening it to substances such as ketamine and testosterone.

Should federal regulations around marijuana become more lenient, it could open doors for cannabis-related businesses. Major stock exchanges might allow the listing of such enterprises, and international companies could potentially enter the U.S. market.

White House Press Secretary Karine Jean-Pierre emphasised that the administration’s process is rooted in evidence and led by independent bodies such as HHS and the Department of Justice.

North of the border, cannabis has gained legal status in Canada, creating a haven for publicly traded cannabis businesses. Many of these Canadian entities are poised to expand into the U.S. market if federal legalisation progresses.

News of the proposed shift triggered a surge in the stock prices of various cannabis companies. Notable firms like Canopy Growth, Tilray Brands, and Cronos Group experienced stock price increases, while entities such as Verano Holdings and Sunburn Cannabis expressed support for the HHS’s move.

George Archos, CEO of Verano Holdings, articulated the sentiment shared among advocates for marijuana reform, citing the outdated scheduling status of cannabis as a hindrance and emphasising the harm caused by the historical “War on Drugs.”

The HHS’s recommendation marks a notable development in the ongoing dialogue surrounding marijuana’s legal status in the United States, potentially setting the stage for a broader reconsideration of its classification and the resulting implications.

Continue Reading

News

China faces economic slowdown amid Trump’s tariffs

China faces pressure to hit a 5% growth target amidst US tariffs, with analysts urging a 2 trillion yuan stimulus to mitigate trade war effects.

Published

on

China faces pressure to hit a 5% growth target amidst US tariffs, with analysts urging a 2 trillion yuan stimulus to mitigate trade war effects.


China is under pressure to meet its 5% growth target this year as US tariffs bite.

Analysts are calling for a major stimulus package—up to 2 trillion yuan—to combat trade war fallout.

This episode explores what measures Beijing may take, and whether Chinese consumers can help steady the ship.

#ChinaEconomy #TrumpTariffs #GlobalTrade #Stimulus #ChineseGrowth #Beijing #ConsumerSpending #TickerNews

Continue Reading

News

Tariffs shake tech sector and US dollar stability

“Amid global tariffs and tech giants’ warnings, we explore economic stability and the US dollar’s role with insights from David Scutt and Australia’s resilient jobs report.”

Published

on

“Amid global tariffs and tech giants’ warnings, we explore economic stability and the US dollar’s role with insights from David Scutt and Australia’s resilient jobs report.”


As tariffs ripple through global markets, questions emerge about tech stability and the US dollar’s safe-haven status.

With giants like Nvidia and ASML raising red flags, are we looking at isolated concerns—or a broader systemic risk?

Plus, Australia’s jobs report shows resilience. We discuss with David Scutt from StoneX.

#TechStocks #USDollar #Nvidia #ASML #GlobalMarkets #TradeWar #EconomicForecast #TickerNews

Continue Reading

News

Powell warns tariffs may slow US economy

Powell says US economy strong, but warns Trump’s tariffs may cause inflation and growth risks; impacts on Wall Street and investors dissected. #JeromePowell #FederalReserve #USEconomy #Tariffs #Inflation #StockMarket #TrumpTariffs #TickerNews

Published

on

Powell says US economy strong, but warns Trump’s tariffs may cause inflation and growth risks; impacts on Wall Street and investors dissected. #JeromePowell #FederalReserve #USEconomy #Tariffs #Inflation #StockMarket #TrumpTariffs #TickerNews


Federal Reserve Chair Jerome Powell says the US economy remains strong, but Trump’s tariffs may threaten growth.

Powell warns that these trade barriers could trigger higher inflation, slower growth, and financial market volatility.

We break down what Powell said and what it means for Wall Street and everyday investors.

#JeromePowell #FederalReserve #USEconomy #Tariffs #Inflation #StockMarket #TrumpTariffs #TickerNews

Continue Reading

Trending Now